Effect of angiotensin type I-receptor blockade on left ventricular remodeling in pressure overload hypertrophy

Journal of Cardiac Failure

Volumn 7, Issue 4, 2001, Pages 342-347

  Kiatchoosakun, Songsak ^a   Lawrence, Earl ^a   Nakada, Shigekazu ^a   Restivo, Joseph ^a   Walsh, Richard A ^a   Hoit, Brian D ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Echocardiography; Isolated heart mechanics; Left ventricular mass; Ventricular function

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DESCENDING AORTA; ECHOCARDIOGRAPHY; GUINEA PIG; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0035654317     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2001.29785     Document Type: Article

References (35)

1. The cellular pathophysiology of progression to heart failure
2. Growth and hypertrophy of the heart and vessels
3. Left ventricular hypertrophy: Pathogenesis, detection, and prognosis
4. Structural basis for heart failure: Ventricular remodeling and its pharmacological inhibition
5. Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling
6. The renin-angiotensin system and experimental heart failure
7. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systemic overview of data from individual patients
8. Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon
9. Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species considerations
10. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation
11. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vivo
12. Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure
13. 2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure
14. Transition from hypertrophy to failure
15. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
16. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
17. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
18. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
19. Influence of chronic captropril therapy on the infracted ventricle of the rat
20. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure
21. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis
22. Long-term angiotensin II type I receptor blockade with fonsartan doubles lifespan of hypertensive rats
23. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats
24. Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients
25. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type I receptor blockade on cardiac remodeling after myocardial infarction in the rat
26. Survival after myocardial infarction in rats: Captopril versus losartan
27. Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats
28. Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure
29. Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype I receptor blockade on ventricular remodeling in the dog
30. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems
31. Pressure overload induces cardiac hypertrophy in angiotensin II type IA receptor knockout mice
32. Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type Ia receptor knockout mice
33. Insights from animal models of myocardial infarction: Do ACE inhibitors limit the structural response?
34. Mechanisms and models in heart failure: A combinatorial approach
35. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type I receptor in B(2) kinin receptor gene knockout mice